CBDL (CBD Life Sciences) LT-Debt-to-Total-Asset: 0.00 (As of Sep. 2015)


What is CBD Life Sciences LT-Debt-to-Total-Asset?

CBD Life Sciences CBDL -16.67% LT-Debt-to-Total-Asset is 0.00 as of Sep. 2015.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CBD Life Sciences's long-term debt to total assests ratio for the quarter that ended in Sep. 2015 was 0.00.

CBD Life Sciences's long-term debt to total assets ratio stayed the same from Sep. 2014 (0.00) to Sep. 2015 (0.00).

CBD Life Sciences  (OTCPK:CBDL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CBD Life Sciences LT-Debt-to-Total-Asset Related Terms

CBD Life Sciences LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences LT-Debt-to-Total-Asset Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
LT-Debt-to-Total-Asset
0.00 0.00 0.00 0.00

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBD Life Sciences LT-Debt-to-Total-Asset Calculation

CBD Life Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2014 is calculated as

LT Debt to Total Assets (A: Dec. 2014 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2014 )/Total Assets (A: Dec. 2014 )
=0/0.632
=0.00

CBD Life Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2015 is calculated as

LT Debt to Total Assets (Q: Sep. 2015 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2015 )/Total Assets (Q: Sep. 2015 )
=0/0.621
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
CBD Life Sciences (CBDL) has a LT-Debt-to-Total-Asset of 0.00 as of Sep. 2015. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on CBD Life Sciences and its competitors.
Is CBD Life Sciences' LT-Debt-to-Total-Asset too high?
CBD Life Sciences' current LT-Debt-to-Total-Asset is 0.00.
How does CBD Life Sciences' LT-Debt-to-Total-Asset compare to QPAG and ADGO?
CBD Life Sciences' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on CBD Life Sciences and its competitors. CBD Life Sciences's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current LT-Debt-to-Total-Asset is 0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.